AHB Lab Third-Generation Biosynthetic Peptides | Global Partnership Opportunities

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab

Table of Contents

Partner With Us to Shape the Next Generation of Peptide-Based Health and Wellness

Seeking Distributors | Sales Agents | Group-Buying Partners | Retail & E-Commerce Partners

AHB Lab, a division of Peptide Biotech Co., Ltd., specializes in the research, scalable manufacturing, and commercial application of third-generation biosynthetic peptides.

At the core of our innovation is our proprietary SBPP (Synthetic Biopeptide Production Platform), which enables us to continuously transform advanced peptide technologies into commercially viable ingredients and finished products with broad market potential.

We believe the true value of biotechnology extends far beyond the laboratory. Great technology should reach the marketplace, move through distribution channels, and ultimately become part of consumers’ everyday lives.

AHB Lab is now inviting partners with expertise in market development, channel management, and sales to join us in unlocking new opportunities for third-generation biosynthetic peptides.

From “Peptide Manufacturing” to “Life-Signal Programming”

Conventional hydrolyzed peptides are characterized by randomly generated peptide sequences, while chemically synthesized peptides face limitations related to manufacturing costs and process complexity.

AHB Lab integrates biological programming, intelligent fermentation, precision enzymatic cleavage and purification, and scalable manufacturing to introduce specific target peptide sequences into biological systems.

Through this approach, we have established a next-generation technology platform that advances peptide production from “peptide manufacturing” toward “life-signal programming.”

Through our proprietary technology platform, our goal is to bring sequenced-peptide technology—traditionally associated with high technical barriers—toward scalable manufacturing, commercialization, and broader market adoption.

From Proprietary Peptide Ingredients to Finished Products: Building a Comprehensive Product Portfolio

AHB Lab has brought 13 proprietary biosynthetic peptide ingredients into commercial-scale production and continues to develop new biosynthetic peptides, extending our core technology into a wide range of consumer markets.

Our current product portfolio includes:

ORALTIDE | Oral Care

Daily oral and periodontal care

FACIALTIDE | Facial Care

Anti-wrinkle, skin-firming, and smoothing care

NEWLYTIDE | Mobility Care

Sports recovery and joint care

NEUTRITIDE | Nutritional Health

20 product applications for preventive health and wellness management

From biosynthetic peptide ingredients → formulation development → finished products → branded market applications, AHB Lab is building a comprehensive commercialization ecosystem for next-generation peptide products.

Why Partner With AHB Lab?

Proprietary SBPP Technology Platform

Our proprietary SBPP biosynthetic peptide manufacturing technology provides a differentiated technological foundation for both product development and market positioning.

Precision Sequencing

We advance beyond conventional “random hydrolysis” to develop biosynthetic peptides with clearly defined sequences and targeted applications.

Scalable Manufacturing Capabilities

We transform laboratory-stage peptide technologies into commercially scalable ingredients that support finished-product development and market expansion.

Green Biomanufacturing

Our biomanufacturing approach helps overcome the limitations associated with conventional chemical synthesis while advancing toward a more scalable and sustainable manufacturing model.

Proprietary Ingredients × Branded Products

AHB Lab goes beyond supplying individual peptide ingredients. We have developed a broad application portfolio spanning oral care, skin care, everyday mobility support, and nutritional health.

Flexible Market Partnership Models

Based on each partner’s existing distribution channels, customer base, and market strengths, we can jointly develop product and sales strategies tailored to specific market opportunities.

We’re Looking for Partners Like You

Distributors

Ideal for partners with established regional markets, customer networks, and sales teams who are interested in expanding the market presence of AHB Lab products and brands.

Sales Agents

We welcome partners with expertise in brand development, market expansion, and channel integration to explore regional or market-specific sales representation opportunities.

Retail & E-Commerce Partners

E-commerce platforms, retail chains, specialty retailers, and other sales-channel partners are welcome to explore product listings, retail distribution, and channel partnership opportunities.

Corporate & Institutional Buyers

We also welcome corporate employee welfare committees, employee benefits platforms, and other organizations interested in corporate purchasing and customized partnership programs.

AHB Lab Technology & Products × Your Market & Channels

AHB Lab brings expertise in peptide technology, ingredient R&D, and product innovation.

Our partners bring expertise in market insights, brand communication, channel development, and consumer engagement.

By combining these complementary strengths, we aim to build health and wellness businesses with meaningful technological differentiation and sustainable long-term market competitiveness.

We are looking for more than one-time product transactions. We seek partners who share our vision for developing markets, generating sustainable revenue, and building long-term value together.

Become an AHB Lab Market Partner

If your business operates in:

Health & Wellness | Oral Care | Beauty & Skin Care | Lifestyle Wellness | Innovative Biotechnology Products

and you have expertise in brand promotion, community engagement, distribution, retail channels, or market development, we invite you to connect with AHB Lab.

After an initial discussion to understand our respective market strategies and capabilities, we can explore the partnership model that best fits both organizations, including:

Distribution | Sales Representation | Retail & E-Commerce Channels | Corporate Purchasing | Other Strategic Market Partnerships

Bringing Innovative Technology to Market—and Great Products Into More People’s Everyday Lives

AHB Lab invites you to become one of our market partners and join us in expanding the next generation of third-generation biosynthetic peptide products into new markets.

[CONTACT US ABOUT PARTNERSHIP OPPORTUNITIES]

AHB Lab | Peptide Biotech Co., Ltd.
Global Peptide Expert

Phone: +886-2-2240-6699
Email: patrick_wang@ahb-lab.com

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

你的消炎藥只是在「關掉煙霧探測器」?從源頭阻斷慢性發炎的胜肽科學

為什麼你的疲倦與疼痛總是反覆發作? 你是不是經常覺得關節痠痛、莫名疲倦,或者有各種過敏和腸胃問題,卻始終找不出確切原因 ? 在現代高壓與快節奏的生活中,許多人都在尋求這些亞健康狀態的解藥。事實上,現代人90%的慢性病,其實都來自同一個源頭:你體內有一把撲不滅的「無名火」,醫學上稱之為「慢性發炎」 。 當面臨這些不適,多數人的第一反應是服用非類固醇消炎藥(NSAIDs)或類固醇。然而,這些傳統藥物往往只能提供短暫的舒緩,一旦停藥,症狀便會捲土重來。這不禁讓我們反思:我們是否只在處理表面症狀,而忽略了真正的問題根源?   傳統消炎藥的盲點與機制 要理解傳統藥物的局限性,我們必須先了解發炎的運作機制。當身體受到外界刺激時,免疫系統中的「巨噬細胞」會釋放 TNF-α 和 IL-1β 等發炎細胞因子 。這本是身體為了防禦而響起的警報器,但當免疫系統失衡,這些發炎因子便會失控形成「細胞因子風暴」,開始無差別攻擊正常細胞、黏膜和關節,甚至破壞 DNA 。 傳統的西藥如 NSAIDs 是如何運作的呢?它們主要的作用機制是抑制下游的 COX-1 或 COX-2 酵素 。 為了讓大家更直觀地理解,我們可以比較一下這兩種機制的差異:

Read More
公司最新訊息

止痛藥的隱形代價:淨火肽如何透過「8小時降解」機制重塑無毒抗炎新標準?

引言 在現代高壓的生活節奏中,面對關節痠痛或慢性疲勞,多數人的第一反應往往是去藥房購買非類固醇消炎止痛藥,或是服用醫生開立的類固醇 。當藥效發揮,疼痛的警報聲停止,我們便誤以為身體恢復了健康 。 然而,你吞下的那顆止痛藥,在讓你感覺不到痛之後,究竟去了哪裡? 這是一個多數消費者忽略,而品牌研發端必須正視的痛點。傳統藥物在體內的作用機制,實際上只是粗暴地抑制了下游的 COX 酵素 。這就像是一群莽漢直接砸爛了火災警報器,卻對真正引發火災的源頭無能為力 。更嚴重的是,這些無法被身體完全辨識與利用的化學合成物,在完成掩蓋任務後並不會憑空消失,而是轉化為化學廢棄物 。 這些殘留物迫使肝臟超負荷運作以進行代謝,同時也讓腎臟拼命處理排毒 。由於 COX 酵素被過度抑制,人體保護胃壁的機制隨之停擺,最終導致腸胃黏膜逐漸受到破壞 。這不是真正的治療,而是一場用內臟健康換取短暫不痛的恐怖交易 。身為保健或保養品牌的決策者,我們必須思考:除了這種「拆東牆補西牆」的化學療法,我們能否為市場提供一種更安全、無毒的解答?   核心機制深潛 為了解決傳統消炎藥物的瓶頸,富比積生物科技(AHB Lab)突破傳統藥理學限制,研發出名為「淨火肽 Healtide®」的第三代生物合成定序胜肽 。這項技術透過「生物黑客」的思維,重新定義了抗炎機制的標準。   1.

Read More